Works matching IS 00071048 AND DT 2021 AND VI 193 AND IP 3

Results: 35
    1
    2
    3

    Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 592, doi. 10.1111/bjh.17426
    By:
    • Kharfan‐Dabaja, Mohamed A.;
    • Labopin, Myriam;
    • Brissot, Eolia;
    • Kroger, Nicolaus;
    • Finke, Jürgen;
    • Ciceri, Fabio;
    • Deconinck, Eric;
    • Blaise, Didier;
    • Chevallier, Patrice;
    • Gramatzki, Martin;
    • Ganser, Arnold;
    • Stelljes, Matthias;
    • Edinger, Matthias;
    • Savani, Bipin;
    • Ruggeri, Annalisa;
    • Sanz, Jaime;
    • Nagler, Arnon;
    • Mohty, Mohamad
    Publication type:
    Article
    4

    Drop metastases in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 444, doi. 10.1111/bjh.17305
    By:
    • Fisken, Rachel;
    • Abuhassan, Arieff;
    • Smith, Dean
    Publication type:
    Article
    5

    Erratum.

    Published in:
    2021
    Publication type:
    Correction Notice
    6

    Identification of CXCL12‐abundant reticular cells in human adult bone marrow.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 659, doi. 10.1111/bjh.17396
    By:
    • Aoki, Kazunari;
    • Kurashige, Masako;
    • Ichii, Michiko;
    • Higaki, Kei;
    • Sugiyama, Tatsuki;
    • Kaito, Takashi;
    • Ando, Wataru;
    • Sugano, Nobuhiko;
    • Sakai, Takashi;
    • Shibayama, Hirohiko;
    • Takaori‐Kondo, Akifumi;
    • Morii, Eiichi;
    • Kanakura, Yuzuru;
    • Nagasawa, Takashi
    Publication type:
    Article
    7
    8

    Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
    By:
    • Kunacheewa, Chutima;
    • Feng, Lei;
    • Manasanch, Elisabet E.;
    • Bashir, Qaiser;
    • Patel, Krina K.;
    • Mehta, Rohtesh;
    • Kaufman, Gregory P.;
    • Srour, Samer;
    • Saini, Neeraj;
    • Iyer, Swaminathan P.;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Qazilbash, Muzaffar H.;
    • Lee, Hans C.
    Publication type:
    Article
    9

    Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. e19, doi. 10.1111/bjh.17391
    By:
    • Popat, Rakesh;
    • Counsell, Nicholas;
    • de Tute, Ruth;
    • De‐Silva, Dunnya;
    • Phillips, Elizabeth H.;
    • Cavenagh, Jamie D.;
    • Adedayo, Toyin;
    • Braganca, Nivette;
    • Roddie, Claire;
    • Streetly, Matthew;
    • Schey, Steve;
    • Koh, Mickey B. C.;
    • Crowe, Josephine;
    • Morris, Treen C.;
    • Cook, Gordon;
    • Smith, Paul;
    • Clifton‐Hadley, Laura;
    • Rabin, Neil;
    • Owen, Roger;
    • Yong, Kwee
    Publication type:
    Article
    10
    11

    Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy: implications for flow cytometric detection of minimal residual disease

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 602, doi. 10.1111/bjh.17382
    By:
    • Mikhailova, Ekaterina;
    • Semchenkova, Alexandra;
    • Illarionova, Olga;
    • Kashpor, Svetlana;
    • Brilliantova, Varvara;
    • Zakharova, Elena;
    • Zerkalenkova, Elena;
    • Zangrando, Andrea;
    • Bocharova, Natalia;
    • Shelikhova, Larisa;
    • Diakonova, Yulia;
    • Zhogov, Vladimir;
    • Khismatullina, Rimma;
    • Molostova, Olga;
    • Buldini, Barbara;
    • Raykina, Elena;
    • Larin, Sergey;
    • Olshanskaya, Yulia;
    • Miakova, Natalia;
    • Novichkova, Galina
    Publication type:
    Article
    12

    Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 674, doi. 10.1111/bjh.17380
    By:
    • Pasquer, Hélène;
    • Belhadj, Karim;
    • Dupuis, Jehan;
    • Oghina, Sylvia;
    • Galat, Antoine;
    • Ladaique, Amandine;
    • Maarek, Alizée;
    • Roulin, Louise;
    • Gounot, Romain;
    • Poulot, Elsa;
    • Beldi‐Ferchiou, Asma;
    • Molinier‐Frenkel, Valérie;
    • Haioun, Corinne;
    • Damy, Thibaud;
    • Le Bras, Fabien;
    • Lemonnier, François
    Publication type:
    Article
    13
    14
    15
    16
    17

    Vasculo‐toxic and pro‐inflammatory action of unbound haemoglobin, haem and iron in transfusion‐dependent patients with haemolytic anaemias.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 637, doi. 10.1111/bjh.17361
    By:
    • Vinchi, Francesca;
    • Sparla, Richard;
    • Passos, Sara T.;
    • Sharma, Richa;
    • Vance, S. Zebulon;
    • Zreid, Hala S.;
    • Juaidi, Hesham;
    • Manwani, Deepa;
    • Yazdanbakhsh, Karina;
    • Nandi, Vijay;
    • Silva, André M. N.;
    • Agarvas, Anand R.;
    • Fibach, Eitan;
    • Belcher, John D.;
    • Vercellotti, Gregory M.;
    • Ghoti, Husam;
    • Muckenthaler, Martina U.
    Publication type:
    Article
    18

    MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 497, doi. 10.1111/bjh.17357
    By:
    • Ferreri, Andrés J. M.;
    • Calimeri, Teresa;
    • Lopedote, Paolo;
    • Francaviglia, Ilaria;
    • Daverio, Rita;
    • Iacona, Chiara;
    • Belloni, Cristina;
    • Steffanoni, Sara;
    • Gulino, Alessandro;
    • Anghileri, Elena;
    • Diffidenti, Angelo;
    • Finardi, Annamaria;
    • Gagliardi, Filippo;
    • Anzalone, Nicoletta;
    • Nonis, Alessandro;
    • Furlan, Roberto;
    • De Lorenzo, Daniela;
    • Terreni, Maria R.;
    • Martinelli, Vittorio;
    • Sassone, Marianna
    Publication type:
    Article
    19
    20

    Real‐world outcomes with bortezomib‐containing regimens and lenalidomide plus dexamethasone for the treatment of transplant‐ineligible multiple myeloma: a multi‐institutional report from the Canadian Myeloma Research Group database

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 532, doi. 10.1111/bjh.17350
    By:
    • Jimenez‐Zepeda, Victor H.;
    • Venner, Christopher;
    • McCurdy, Arleigh;
    • Masih‐Khan, Esther;
    • Atenafu, Eshetu G.;
    • Sebag, Michael;
    • Stakiw, Julie;
    • Song, Kevin;
    • LeBlanc, Richard;
    • Reiman, Tony;
    • Louzada, Martha;
    • Kotb, Rami;
    • Gul, Engin;
    • Reece, Donna
    Publication type:
    Article
    21

    Molecular dynamics of targeting CD38 in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 581, doi. 10.1111/bjh.17329
    By:
    • Malavasi, Fabio;
    • Faini, Angelo C.;
    • Morandi, Fabio;
    • Castella, Barbara;
    • Incarnato, Danny;
    • Oliviero, Salvatore;
    • Horenstein, Alberto L.;
    • Massaia, Massimo;
    • Donk, Niels W. C. J.;
    • Richardson, Paul G.
    Publication type:
    Article
    22
    23

    Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 561, doi. 10.1111/bjh.17321
    By:
    • Hungria, Vania;
    • Beksac, Meral;
    • Weisel, Katja C.;
    • Nooka, Ajay K.;
    • Masszi, Tamas;
    • Spicka, Ivan;
    • Munder, Markus;
    • Mateos, María‐Victoria;
    • Mark, Tomer M.;
    • Qi, Ming;
    • Qin, Xiang;
    • Fastenau, John;
    • Spencer, Andrew;
    • Sonneveld, Pieter;
    • Garvin, Wendy;
    • Renaud, Thomas;
    • Gries, Katharine S.
    Publication type:
    Article
    24
    25

    Multiple myeloma with hungry plasma cells.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 443, doi. 10.1111/bjh.17299
    By:
    • Rieu, Jean‐Baptiste;
    • Perrot, Aurore;
    • Vergnolle, Ines;
    • Schavgoulidze, Anais;
    • Corre, Jill
    Publication type:
    Article
    26

    Incorporation of somatic panels for the detection of haematopoietic transformation in children and young adults with leukaemia predisposition syndromes and with acquired cytopenias.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 570, doi. 10.1111/bjh.17285
    By:
    • Noy‐Lotan, Sharon;
    • Krasnov, Tanya;
    • Dgany, Orly;
    • Jeison, Marta;
    • Yanir, Asaf D.;
    • Gilad, Oded;
    • Toledano, Helen;
    • Barzilai‐Birenboim, Shlomit;
    • Yacobovich, Joanne;
    • Izraeli, Shai;
    • Tamary, Hannah;
    • Steinberg‐Shemer, Orna
    Publication type:
    Article
    27
    28

    Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 482, doi. 10.1111/bjh.17213
    By:
    • Hjort Jakobsen, Lasse;
    • Stidsholt Roug, Anne;
    • Kiesbye Øvlisen, Andreas;
    • Werenberg Marcher, Claus;
    • Beier Ommen, Hans;
    • Theilgaard‐Mönch, Kim;
    • Møller, Peter;
    • Schöllkopf, Claudia;
    • Kristensen, Daniel;
    • Maria Henriette Naur, Therese;
    • Bøgsted, Martin;
    • Christoffer El‐Galaly, Tarec;
    • Tang Severinsen, Marianne
    Publication type:
    Article
    29
    30
    31

    The detection of circulating plasma cells may improve the Revised International Staging System (R‐ISS) risk stratification of patients with newly diagnosed multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 542, doi. 10.1111/bjh.17118
    By:
    • Galieni, Piero;
    • Travaglini, Fosco;
    • Vagnoni, Davide;
    • Ruggieri, Miriana;
    • Caraffa, Patrizia;
    • Bigazzi, Catia;
    • Falcioni, Sadia;
    • Picardi, Paola;
    • Mazzotta, Serena;
    • Troiani, Emanuela;
    • Dalsass, Alessia;
    • Mestichelli, Francesca;
    • Angelini, Mario;
    • Camaioni, Elisa;
    • Maravalle, Denise;
    • Angelini, Stefano;
    • Pezzoni, Valerio
    Publication type:
    Article
    32
    33
    34

    Issue Information.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 433, doi. 10.1111/bjh.16829
    Publication type:
    Article
    35

    Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 551, doi. 10.1111/bjh.16793
    By:
    • Bygrave, Ceri;
    • Pawlyn, Charlotte;
    • Davies, Faith;
    • Craig, Zoe;
    • Cairns, David;
    • Hockaday, Anna;
    • Jenner, Matthew;
    • Cook, Gordon;
    • Drayson, Mark;
    • Owen, Roger;
    • Gregory, Walter;
    • Morgan, Gareth;
    • Jackson, Graham;
    • Kaiser, Martin
    Publication type:
    Article